FDA product code QUV: Phase-Changing Fiducial Marker For Radiation Therapy

QUV is the FDA product code for phase-changing fiducial marker for radiation therapy. It is a Class II device, regulated under 21 CFR 892.5727 and reviewed by the Radiology panel. Devices under QUV reach the market by 510(k); FDA lists no cleared 510(k)s for it. 1 De Novo request was granted under it.

Definition

A phase-changing fiducial marker for radiation therapy is a single-use, sterile liquid material that changes phase in situ when injected in tissue for the purposes of aiding radiation therapy treatment. The device is intended to be visualized using one or more radiologic imaging modalities.

Classification

FieldValue
Device namePhase-Changing Fiducial Marker For Radiation Therapy
Device classClass II
Regulation21 CFR 892.5727
Review panelRA — Radiology
Medical specialtyRadiology
Premarket route510(k)
ImplantYes

Recalls for QUV devices

FDA recall records list no recalls for product code QUV.

Frequently asked questions

What is FDA product code QUV?

QUV is the FDA product code for phase-changing fiducial marker for radiation therapy. It is a Class II device, regulated under 21 CFR 892.5727 and reviewed by the Radiology panel.

What device class is QUV?

Class II, regulation 21 CFR 892.5727. Typical premarket route: 510(k).

Next steps

Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.

All Radiology product codes · FDA product code lookup · 510(k) database search · 510(k) review times